Evidence map›Paper›PMID 42774474›Full record

ArticleFrontiers in pharmacology2026

Treatment of neuropathic pain in diabetic rats with synergistic combinations of nortriptyline + tramadol and nortriptyline + ibuprofen.

M Gicela Pérez-Hernández, Alberto Sesena-Rubfiaro, Ángel D Trillo-Arenazas, Yolitzy Cárdenas, Miguel Huerta, Xóchitl Trujillo, Enrique A Sánchez-Pastor, M Irene Díaz-Reval

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

M Gicela Pérez-HernándezFaculty of Nursing, University of Colima, Colima, Mexico.
Alberto Sesena-RubfiaroMolecular Sciences, A.I. Virtanem Institute, University of Eastern Finland, Kuopio, Finland.
Ángel D Trillo-ArenazasUniversity Center for Biomedical Research, University of Colima, Colima, Mexico.
Yolitzy CárdenasUniversity Center for Biomedical Research, University of Colima, Colima, Mexico.
Miguel HuertaUniversity Center for Biomedical Research, University of Colima, Colima, Mexico.
Xóchitl TrujilloUniversity Center for Biomedical Research, University of Colima, Colima, Mexico.
Enrique A Sánchez-PastorUniversity Center for Biomedical Research, University of Colima, Colima, Mexico.
M Irene Díaz-RevalUniversity Center for Biomedical Research, University of Colima, Colima, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Neuropathic pain in diabetic patients is very difficult to treat and does not respond to conventional analgesic treatments. It has been observed that tricyclic antidepressants are able to reduce this type of pain. In some animal experimental models, drug combinations have yielded better results. Thus, this study analyzed the type of synergism produced by the combinations of Nortriptyline + Tramadol and Nortriptyline + Ibuprofen in streptozotocin-induced diabetic rats. Methodology: Hyperglycemia was induced by administering 65 mg/kg i.p. of streptozotocin to Wistar rats. The formalin model was used to evaluate hyperalgesia with administration of formalin at 0.5%. The effects of tramadol, ibuprofen, and nortriptyline as monotherapies were evaluated. The doses administered in combination were determined using the mean effective doses of each drug and the constant-ratio method. An isobolographic analysis was performed to determine the type of synergism. Results: Nortriptyline, Tramadol, and Ibuprofen showed an antihyperalgesic effect dose-dependent. Nortriptyline was the most effective and most potent; its maximum effect was 96.67% ± 1.52%, and the ED Conclusion: Our study demonstrates that combinations of Nortriptyline with either Tramadol or Ibuprofen are more effective at lower doses than the drugs alone. A supra-additive synergism has been observed for both combinations, which may be useful in the management of neuropathic pain caused by diabetes.

Indexed as

diabetesibuprofenneuropathic painnortriptylinesynergismtramadol

Identifiers

PMID42774474
PMCPMC13594581

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.